Effects of cyclodextrins on drug delivery through biological membranes

被引:259
作者
Loftsson, Thorsteinn
Vogensen, Stine Byskov
Brewster, Marcus E.
Konradsdottir, Fifa
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
[2] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
关键词
cyclodextrin; drug delivery; unstirred water layer; water structure; permeation; membrane;
D O I
10.1002/jps.20992
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclodextrins have proven themselves to be useful functional excipients. Cyclodextrin derivatives can be hydrophilic or relatively lipophilic based on their substitution and these properties can give insight into their ability to act as permeability enhancers. Lipophilic cyclodextrins such as the methylated derivatives are thought to increase drug flux by altering barrier properties of the membrane through component extraction or fluidization. The hydrophilic cyclodextrin family also modulate drug flux through membranes but via different mechanisms. The current effort seeks to provide various explanations for these observations based on interactions of hydrophilic cyclodextrins with the unstirred water layer that separates the bulk media from biological membranes such as the gastric mucosa, cornea and reproductive tract. Theories on the serial nature of resistances to drug flux are used to explain why hydrophilic cyclodextrins can enhance drug uptake in some situation (i.e., for lipophilic material) but not in others. In addition, the nature of secondary equilibria and competition between cyclodextrins and rheologically important biopolymers such as mucin are assessed to give a complete picture of the effect of these starch derivatives. This information can be useful not only in understanding the actions of cyclodextrin but also in expanding their application and uses. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:2532 / 2546
页数:15
相关论文
共 109 条
[91]   Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben [J].
Tanaka, M ;
Iwata, Y ;
Kouzuki, Y ;
Taniguchi, K ;
Matsuda, H ;
Arima, H ;
Tsuchiya, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (11) :897-900
[92]   Cyclodextrin drug carrier systems [J].
Uekama, K ;
Hirayama, F ;
Irie, T .
CHEMICAL REVIEWS, 1998, 98 (05) :2045-2076
[93]  
UEKAMA K, 1987, CHEM PHARM BULL, V35, P2910
[94]   IMPROVED TRANSDERMAL DELIVERY OF PROSTAGLANDIN-E1 THROUGH HAIRLESS MOUSE SKIN - COMBINED USE OF CARBOXYMETHYL-ETHYL-BETA-CYCLODEXTRIN AND PENETRATION ENHANCERS [J].
UEKAMA, K ;
ADACHI, H ;
IRIE, T ;
YANO, T ;
SAITA, M ;
NODA, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (02) :119-121
[95]   Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin [J].
Ventura, C. A. ;
Tommasini, S. ;
Falcone, A. ;
Giannone, I. ;
Paolino, D. ;
Sdrafkakis, V. ;
Mondello, M. R. ;
Puglisi, G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 314 (01) :37-45
[96]   Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex:: characterization and in vitro permeation study [J].
Ventura, CA ;
Giannone, I ;
Paolino, D ;
Pistará, V ;
Corsaro, A ;
Puglisi, G .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (07) :624-631
[97]   Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse [J].
Vitoria, M ;
Bentley, LB ;
Vianna, RF ;
Wilson, S ;
Collett, JH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (04) :397-402
[98]   Structure and reactivity of water at biomaterial surfaces [J].
Vogler, EA .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 1998, 74 :69-117
[99]   Microheterogeneity of ethanol-water binary mixtures observed at the cluster level [J].
Wakisaka, Akihiro ;
Matsuura, Kazuo .
JOURNAL OF MOLECULAR LIQUIDS, 2006, 129 (1-2) :25-32
[100]  
WASHINGTON N, 2001, PHYSL PHARMACEUTICS